RedHill Biopharma Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011223810
Pharmaceuticals
Sales 2022 | 61.8M 23.37B | Sales 2023 | 6.53M 2.47B | Capitalization | 28.72M 10.86B |
---|---|---|---|---|---|
Net income 2022 | -71M -26.85B | Net income 2023 | 23M 8.7B | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 103M 38.83B | Net cash position 2023 | 4.4M 1.66B | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Ori Shilo
FOU | Founder | 57 | 09-08-02 |
Razi Ingber
DFI | Director of Finance/CFO | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 15-12-31 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 10-08-25 |
Director/Board Member | 80 | 10-05-02 |
1st Jan change | Capi. | |
---|---|---|
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+53.80% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
+4.94% | 8.31B |